VINP Vinci shares climb 36 percent after Q4 2025 EPS lands 49 percent below analyst expectations AIDX 2020 Biolabs highlights rising clinical test adoption as core growth driver in latest quarterly earnings J Jacobs Solutions edges down 077 after Q1 2026 EPS lands 1 below analyst consensus estimates